Literature DB >> 48256

Nature of the tumor-associated determinant(s) of carcinoembryonic antigen.

S Hammarström, E Engvall, B G Johansson, S Svensson, G Sundblad, I J Goldstein.   

Abstract

The carbohydrate moiety of carcinoembryonic antigen could be sequentially degraded by repeated cycles of periodate oxidation, reduction, and mild acid hydrolysis (Smith degradation). After three complete degradations, all fucose and sialic acid, 80% of the galactose, 65% of the mannose, and about 40% of the N-acetylglucosamine were eliminated without impairing the ability of degraded carcinoembryonic antigen to react with specific antisera against the antigen. Inhibition studies in a carcinoembryonic antigen/rabbit anti-carcinoembryonic antigen precipitating system with oligosaccharides covering previously known internal structures of glycoproteins and presumably corresponding to the internal carbohydrate region of the antigen, demonstrated that none of the compounds tested was inhibitory. Nor could any inhibitory effect on the binding of carcinoembryonic antigen to antibody against the antigen in a radioimmunoassay system be domonstrated for the carbohydrate moiety prepared by hydrazinolysis or the glyco peptide fraction isolated after papain degradation of the antigen. However, if carcinoembryonic antigen is completely reduced and alkylated, with three intrachain disulfide bonds cleaved per 10-5 g, the immunological activity is reduced to 3-5% of untreated antigen. Furthermore, treatment of the antigen with 0.5 NaOH at 20 degrees for 2 hr completely abolished its ability to react with antiserum, whereas its ability to precipitate with a series of lectins was unchanged. No release of low-molecular-weight carbohydrate orchange in sugar composition of alkali-treated antigen was observed. Our tentative conclusion is that the carbohydrate moiety of carcinoembryonic antigen does not contain the tumor-associated determinant(s).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 48256      PMCID: PMC432570          DOI: 10.1073/pnas.72.4.1528

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Enzyme-linked immunosorbent assay. II. Quantitative assay of protein antigen, immunoglobulin G, by means of enzyme-labelled antigen and antibody-coated tubes.

Authors:  E Engvall; K Jonsson; P Perlmann
Journal:  Biochim Biophys Acta       Date:  1971-12-28

2.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

3.  THE HYDROLYSIS OF CHITIN BY CONCENTRATED HYDROCHLORIC ACID, AND THE PREPARATION OF LOW-MOLECULAR-WEIGHT SUBSTRATES FOR LYSOZYME.

Authors:  J A RUPLEY
Journal:  Biochim Biophys Acta       Date:  1964-11-01

4.  IMMUNOCHEMICAL STUDIES ON BLOOD GROUPS. XXX. CLEAVAGE OF A, B, AND H BLOOD-GROUP SUBSTANCES BY ALKALI.

Authors:  G SCHIFFMAN; E A KABAT; W THOMPSON
Journal:  Biochemistry       Date:  1964-01       Impact factor: 3.162

5.  Immunologically active heterosaccharides of carcinoembryonic antigen of human digestive system.

Authors:  C Banjo; P Gold; S O Freedman; J Krupey
Journal:  Nat New Biol       Date:  1972-08-09

6.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

7.  The preparation of purified carcinoembryonic antigen of the human digestive system from large quantities of tumor tissue.

Authors:  J Krupey; T Wilson; S O Freedman; P Gold
Journal:  Immunochemistry       Date:  1972-06

8.  Purification and characterization of a lectin (plant hemagglutinin) with blood group A specificity from Dolichos biflorus.

Authors:  M E Etzler; E A Kabat
Journal:  Biochemistry       Date:  1970-02-17       Impact factor: 3.162

9.  Preparation of a "chemical vaccine" against tumor progression.

Authors:  W T Shier
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

10.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

View more
  21 in total

1.  Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2.

Authors:  H Uhlig; F Haardt; R Dernick
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  Commercial polyclonal and monoclonal histostaining PAP kits. Immunoperoxidase reagents and performance characteristics in comparison with self-prepared immunoreagents.

Authors:  W D Kuhlmann; P Peschke
Journal:  Histochemistry       Date:  1985

3.  Effects of human alpha-foetoprotein on human B and T lymphocyte proliferation in vitro.

Authors:  R A Murgita; L C Andersson; M S Sherman; H Bennich; H Wigzell
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

4.  Comparison of two enzyme-linked immunosorbent assays for antigen quantitation: direct competition and antibody inhibition.

Authors:  J P Rissing; T B Buxton; R A Talledo; T J Sprinkle
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

Review 5.  Enzyme immunoassays with special reference to ELISA techniques.

Authors:  A Voller; A Bartlett; D E Bidwell
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

6.  Isolation and characterization of the normal crossreacting antigen: homology of its NH2-terminal amino acid sequence with that of carcinoembryonic antigen.

Authors:  E Engvall; J E Shively; M Wrann
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

7.  Mitogenic leukoagglutinin from Phaseolus vulgaris binds to a pentasaccharide unit in N-acetyllactosamine-type glycoprotein glycans.

Authors:  S Hammarström; M L Hammarström; G Sundblad; J Arnarp; J Lönngren
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Carcinoembryonic antigen: evidence for multiple antigenic determinants and isoantigens.

Authors:  R Vrba; E Alpert; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

9.  Evaluation of CEA, CA 19-9, CA-50, CA-195, and TATI with special reference to pancreatic disorders.

Authors:  P Masson; B Pålsson; A Andren-Sandberg
Journal:  Int J Pancreatol       Date:  1991-05

10.  Enzyme immunoassay of the antibody response to Brucella and Yersinia enterocolitica 09 infections in humans.

Authors:  A A Lindberg; S Haeggman; K Karlson; H E Carlsson; N S Mair
Journal:  J Hyg (Lond)       Date:  1982-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.